Beta‐blockers vs calcium channel blockers: Withdrawals due to adverse events
- Population
- Not specified
- Intervention
- Beta‐blockers
- Comparison
- calcium channel blockers
- Outcome
- Withdrawals due to adverse events
Beta‐blockers showed no clear difference in withdrawal due to adverse effect compared with calcium‐channel blockers (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Beta‐blockers vs calcium‐channel blockers Withdrawal due to adverse effect Beta‐blockers showed no clear difference in withdrawal due to adverse effect compared with calcium‐channel blockers (low certainty). Beta‐blockers for hypertension (2017) · Cochrane Headline outcomes only | RR 1.2 [0.71, 2.04] | 2 studies · 21591 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Beta‐blockers vs diuretics · 1 review
- Beta‐blockers vs renin‐angiotensin system inhibitors · 1 review
- Beta‐blockers vs placebo · 1 review
- Beta‐blockers vs placebo · patients with hypertension · 0 reviews
- Beta‐blockers vs renin‐angiotensin system inhibitors · patients with hypertension · 0 reviews
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.